- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
AMCOL International Corporation (NYSE:ACO) announced its first quarter 2012 financial results.
AMCOL International Corporation (NYSE:ACO) announced its first quarter 2012 financial results.
As quoted in the press release:
Net sales increased 8.3% to $235.8 million for the 2012 first quarter, as compared to $217.8 million for the 2011 period. Gross profit increased 12.8% while gross margin increased 110 basis points to 27.6%.
AMCOL’s President and CEO, Ryan McKendrick said:
Our worldwide chromite operations generated steady sales and an operating profit for the quarter despite plant down time incurred to make required equipment upgrades. We continue to start-up and commission new equipment for our chromite processing plant, and we expect this process to be largely completed in Q2 2012.
Click here for the AMCOL International Corporation (NYSE:ACO) press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â